These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 16166587)

  • 1. Activating Notch1 mutations in mouse models of T-ALL.
    O'Neil J; Calvo J; McKenna K; Krishnamoorthy V; Aster JC; Bassing CH; Alt FW; Kelliher M; Look AT
    Blood; 2006 Jan; 107(2):781-5. PubMed ID: 16166587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Notch1 inhibition targets the leukemia-initiating cells in a Tal1/Lmo2 mouse model of T-ALL.
    Tatarek J; Cullion K; Ashworth T; Gerstein R; Aster JC; Kelliher MA
    Blood; 2011 Aug; 118(6):1579-90. PubMed ID: 21670468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OLIG2 (BHLHB1), a bHLH transcription factor, contributes to leukemogenesis in concert with LMO1.
    Lin YW; Deveney R; Barbara M; Iscove NN; Nimer SD; Slape C; Aplan PD
    Cancer Res; 2005 Aug; 65(16):7151-8. PubMed ID: 16103065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Notch1 and mTOR pathways in a mouse T-ALL model.
    Cullion K; Draheim KM; Hermance N; Tammam J; Sharma VM; Ware C; Nikov G; Krishnamoorthy V; Majumder PK; Kelliher MA
    Blood; 2009 Jun; 113(24):6172-81. PubMed ID: 19246562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential mutations in Notch1, Fbxw7, and Tp53 in radiation-induced mouse thymic lymphomas.
    Jen KY; Song IY; Banta KL; Wu D; Mao JH; Balmain A
    Blood; 2012 Jan; 119(3):805-9. PubMed ID: 22117044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia.
    De Keersmaecker K; Lahortiga I; Mentens N; Folens C; Van Neste L; Bekaert S; Vandenberghe P; Odero MD; Marynen P; Cools J
    Haematologica; 2008 Apr; 93(4):533-42. PubMed ID: 18322257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Notch1 contributes to mouse T-cell leukemia by directly inducing the expression of c-myc.
    Sharma VM; Calvo JA; Draheim KM; Cunningham LA; Hermance N; Beverly L; Krishnamoorthy V; Bhasin M; Capobianco AJ; Kelliher MA
    Mol Cell Biol; 2006 Nov; 26(21):8022-31. PubMed ID: 16954387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.
    Weng AP; Ferrando AA; Lee W; Morris JP; Silverman LB; Sanchez-Irizarry C; Blacklow SC; Look AT; Aster JC
    Science; 2004 Oct; 306(5694):269-71. PubMed ID: 15472075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
    Hales EC; Taub JW; Matherly LH
    Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to gamma-secretase inhibitors.
    Palomero T; Barnes KC; Real PJ; Glade Bender JL; Sulis ML; Murty VV; Colovai AI; Balbin M; Ferrando AA
    Leukemia; 2006 Jul; 20(7):1279-87. PubMed ID: 16688224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16Ink4a or p19Arf loss contributes to Tal1-induced leukemogenesis in mice.
    Shank-Calvo JA; Draheim K; Bhasin M; Kelliher MA
    Oncogene; 2006 May; 25(21):3023-31. PubMed ID: 16407836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell acute lymphoblastic leukemia/lymphoma: a human cancer commonly associated with aberrant NOTCH1 signaling.
    Pear WS; Aster JC
    Curr Opin Hematol; 2004 Nov; 11(6):426-33. PubMed ID: 15548998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling T-cell acute lymphoblastic leukemia induced by the SCL and LMO1 oncogenes.
    Tremblay M; Tremblay CS; Herblot S; Aplan PD; Hébert J; Perreault C; Hoang T
    Genes Dev; 2010 Jun; 24(11):1093-105. PubMed ID: 20516195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rag-dependent and Rag-independent mechanisms of Notch1 rearrangement in thymic lymphomas of Atm(-/-) and scid mice.
    Tsuji H; Ishii-Ohba H; Noda Y; Kubo E; Furuse T; Tatsumi K
    Mutat Res; 2009 Jan; 660(1-2):22-32. PubMed ID: 19000702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structurally distinct ligand-binding or ligand-independent Notch1 mutants are leukemogenic but affect thymocyte development, apoptosis, and metastasis differently.
    Priceputu E; Bouallaga I; Zhang Y; Li X; Chrobak P; Hanna ZS; Poudrier J; Kay DG; Jolicoeur P
    J Immunol; 2006 Aug; 177(4):2153-66. PubMed ID: 16887975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Notch signaling contributes to proliferation and tumor formation of human T-cell leukemia virus type 1-associated adult T-cell leukemia.
    Pancewicz J; Taylor JM; Datta A; Baydoun HH; Waldmann TA; Hermine O; Nicot C
    Proc Natl Acad Sci U S A; 2010 Sep; 107(38):16619-24. PubMed ID: 20823234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL.
    Sulis ML; Williams O; Palomero T; Tosello V; Pallikuppam S; Real PJ; Barnes K; Zuurbier L; Meijerink JP; Ferrando AA
    Blood; 2008 Aug; 112(3):733-40. PubMed ID: 18411416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for leukemia- and clone-specific markers at birth in children with T-cell precursor ALL suggests a predominantly postnatal origin.
    Fischer S; Mann G; Konrad M; Metzler M; Ebetsberger G; Jones N; Nadel B; Bodamer O; Haas OA; Schmitt K; Panzer-Grümayer ER
    Blood; 2007 Oct; 110(8):3036-8. PubMed ID: 17557895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch1 is a frequent mutational target in chemically induced lymphoma in mouse.
    Karlsson A; Ungerbäck J; Rasmussen A; French JE; Söderkvist P
    Int J Cancer; 2008 Dec; 123(11):2720-4. PubMed ID: 18798262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haploinsufficiency of the c-myc transcriptional repressor FIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1.
    Matsushita K; Kitamura K; Rahmutulla B; Tanaka N; Ishige T; Satoh M; Hoshino T; Miyagi S; Mori T; Itoga S; Shimada H; Tomonaga T; Kito M; Nakajima-Takagi Y; Kubo S; Nakaseko C; Hatano M; Miki T; Matsuo M; Fukuyo M; Kaneda A; Iwama A; Nomura F
    Oncotarget; 2015 Mar; 6(7):5102-17. PubMed ID: 25671302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.